- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03507647
Mindfulness Based Cognitive Therapy for Bipolar Disorder (MBCT-BD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction:
In the Netherlands, the lifetime prevalence of bipolar disorder (BD) is about 1.2% for men and 1.4% for women (de Graaf et al 2010). BD usually manifests itself during late adolescence or early adulthood. Its course is often chronic, with patients suffering from recurrent depressive, (hypo)manic, or mixed episodes, being symptomatic about half of the time (Judd 2002). Although hospital admissions are more common during manic episodes, illness-related disability is more strongly influenced by depressive episodes (Judd 2003). It has been estimated that about 25-50% of the patients with BD attempts suicide at least once and that the risk of suicide is about 5%(Hawton 2005).
Depressive symptoms in BD are common and have been associated with negative effects on the course of bipolar disorder in terms of functional impairment and quality of life (Gutiérrez-Rojas 2008). There are limited data on how to optimize the treatment of persistent or residual depressive symptoms in BD or to improve outcomes for those patients who do not benefit sufficiently from the available treatments. In addition, there is a need for interventions that not only target symptom reduction but also help patients to cope with their illness from a wider perspective, i.e. in terms of their personal values, goals, and social roles.
Mindfulness-Based Cognitive Therapy (MBCT) is an innovative intervention that has been shown effective in reducing depressive symptoms in unipolar recurrent depression (Aalderen 2012, Kuyken 2016) and appears promising for coping with severe mental illness (Davis and Kurzban 2012). Little is known about the effectiveness of MBCT for BD, with a number of pilot studies showing reductions in depressive symptoms, and one RCT showing reduction of anxiety symptoms. Considering the need for additional psychosocial treatments that not only target symptomatic but also personal recovery, these preliminary but encouraging findings warrant a larger RCT examining the efficacy of MBCT for BD in the Netherlands.
Aims:
As there are limited data on how to improve outcomes for those patients who do not benefit sufficiently from the available treatments, this study aims to compare MBCT to TAU as an adjunctive treatment to reduce depressive symptoms in patients with bipolar disorder. Outcomes of MBCT for BD patients will be examined both on a symptom level (depression, mania, anxiety, risk of relapse/recurrence) and in terms of functioning and mental health/well-being, including its possible working mechanisms such as improvements of mindfulness and self-compassion skills.
Method:
A randomized, multicenter, prospective, evaluator-blinded clinical trial of MBCT added to treatment as usual (TAU) versus TAU alone. Assessments will be conducted at baseline and at 3, 6, 9, 12 and 15 months follow-up.
The intervention will consist of usual care, and for half of the participants MBCT will be offered in adjunct. MBCT is a manualised group skills-training program (Segal, Williams & Teasdale 2012) designed as a relapse prevention programme for patients with recurrent depression. The training consists of eight weekly sessions of 2.5 hours, plus one day of silent practice. The program includes both formal and informal meditation exercises. Cognitive techniques that are part of the program are education, monitoring and scheduling of activities, identification of negative automatic thoughts and devising a relapse prevention plan.
The MBCT treatment will based on the 8-week MBCT course developed by Segal, Williams and Teasdale (2012), but will be adapted to address the needs of patients with a bipolar disorder. A few examples of these adaptations are: (more) psychoeducation about manic symptoms in addition to the psychoeducation about depression; introducing the 3-minute breathing space earlier in the programme and more often during sessions, especially when strong emotions are present; repeatedly bringing the focus to self-care; and making use of the mindful movement (yoga) exercises more frequently. All group sessions will be conducted at the respective mental health centres, with each group comprising 8-12 participants. MBCT courses will be taught by experienced and qualified mindfulness teachers, together with a health care professional specialised in the care for BD patients. Teacher competency will be assessed with the Mindfulness-Based Interventions - Teaching Assessment Criteria (Crane et al 2013), for which all trial sessions will be videotaped.
Usual care will consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Deventer, Netherlands
- Dimence GGZ
-
Nijmegen, Netherlands
- Pro Persona
-
Utrecht, Netherlands
- Altrecht GGZ
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6525 GC
- Radboud University Nijmegen Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- bipolar I or II disorder
- having suffered at least two lifetime depressive episodes, either current or in (partial) remission at baseline (according to SCID assessment)
- Young Mania Rating Scale score < 8
Exclusion Criteria:
- a manic episode in the 3 months before the start of the trial
- lifetime diagnosis of schizophrenia or schizoaffective disorder, current substance abuse disorder, organic brain syndrome, antisocial or borderline personality disorder
- risk of suicide or aggression
- the presence of a concurrent significant medical condition impeding the ability to participate
- currently receiving regular psychological therapy
- previous participation in a MBCT or MBSR course
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness Based Cognitive Therapy added to usual care
Patients in the MBCT arm will be invited to participate in MBCT added to their usual care.
|
MBCT is a manualised group skills-training program (Segal, Williams & Teasdale 2012) consisting of eight weekly sessions of 2.5 hours, plus one day of silent practice. The program includes both formal and informal meditation exercises. Cognitive techniques that are part of the program are education, monitoring and scheduling of activities, identification of negative automatic thoughts and devising a relapse prevention plan. The MBCT treatment will be adapted to address the needs of patients with a bipolar disorder. A few examples of these adaptations are: (more) psychoeducation about manic symptoms in addition to the psychoeduction about depression; introducing the 3-minute breathing space earlier in the programme and more often during sessions, especially when strong emotions are present; repeatedly bringing the focus to self-care; and making use of the mindful movement (yoga) exercises more frequently.
Other Names:
Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).
Usual care will not be restricted, except for proscribing high-frequency psychological interventions such as (group) cognitive behavioral therapy, for practical and methodological reasons.
|
Active Comparator: Usual Care
Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).
|
Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).
Usual care will not be restricted, except for proscribing high-frequency psychological interventions such as (group) cognitive behavioral therapy, for practical and methodological reasons.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inventory of Depressive Symptomatology
Time Frame: Change between baseline and 3 months
|
A clinican-administered interview assessing the severity of depressive symptoms
|
Change between baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Structured Clinical Interview for DSM-IV-TR Disorders
Time Frame: Change between baseline and 15 months
|
Diagnostic instrument to assess relapse of depressive or (hypo)manic episode
|
Change between baseline and 15 months
|
Young Mania Rating Scale
Time Frame: Change between baseline and 3 months
|
Young Mania Rating Scale (YMRS) Dutch translation.
The YMRS is an 11-item clinician-administered rating scale to assess the severity of (hypo)manic symptoms.
It was found to be a reliable, valid, and sensitive rating scale to measure the severity of mania (Young et al., 1978).
Its total score ranges from 0 (no (hypo)manic symptoms) to 44 (severe manic symptoms).
|
Change between baseline and 3 months
|
Young Mania Rating Scale
Time Frame: Change between baseline and 15 months
|
Young Mania Rating Scale (YMRS) Dutch translation.
The YMRS is an 11-item clinician-administered rating scale to assess the severity of (hypo)manic symptoms.
It was found to be a reliable, valid, and sensitive rating scale to measure the severity of mania (Young et al., 1978).
Its total score ranges from 0 (no (hypo)manic symptoms) to 44 (severe manic symptoms).
|
Change between baseline and 15 months
|
Functioning Assessment Short Test
Time Frame: Change between baseline and 3 months
|
Brief instrument designed to assess the main functioning problems experienced by psychiatric patients, particularly bipolar patients
|
Change between baseline and 3 months
|
Functioning Assessment Short Test
Time Frame: Change between baseline and 15 months
|
Brief instrument designed to assess the main functioning problems experienced by psychiatric patients, particularly bipolar patients
|
Change between baseline and 15 months
|
State/Trait Anxiety Inventory
Time Frame: Change between baseline and 3 months
|
self-report measure for assessing both state and trait levels of anxiety
|
Change between baseline and 3 months
|
State/Trait Anxiety Inventory
Time Frame: Change between baseline and 15 months
|
self-report measure for assessing both state and trait levels of anxiety
|
Change between baseline and 15 months
|
Ruminative Response Scale - brooding subscale
Time Frame: Change between baseline and 3 months
|
Brooding subscale of the extended version of the Ruminative Response Scale (RRS-EXT).
The authors reported adequate internal consistency (α = .79)
and test-retest stability (α = .62,
with a one year time interval) for the brooding subscale, which consists of five items.
We select the brooding subscale because over time, brooding, or rumination, has been more strongly related to levels of depression (Treynor et al., 2003).
Items are scored between 1 ((almost) never) to 4 ((almost) always and subscale score ranges between 5 and 20.
A higher score indicates a higher level of ruminative brooding.
|
Change between baseline and 3 months
|
Ruminative Response Scale - brooding subscale
Time Frame: Change between baseline and 15 months
|
Brooding subscale of the extended version of the Ruminative Response Scale (RRS-EXT).
The authors reported adequate internal consistency (α = .79)
and test-retest stability (α = .62,
with a one year time interval) for the brooding subscale, which consists of five items.
We select the brooding subscale because over time, brooding, or rumination, has been more strongly related to levels of depression (Treynor et al., 2003).
Items are scored between 1 ((almost) never) to 4 ((almost) always and subscale score ranges between 5 and 20.
A higher score indicates a higher level of ruminative brooding.
|
Change between baseline and 15 months
|
Five Facet Mindfulness Questionnaire, short form
Time Frame: Change between baseline and 3 months
|
Self-report measure consisting of 24 items divided into the subscales observing, describing, acting with awareness, non-judging and non-reactivity.
|
Change between baseline and 3 months
|
Five Facet Mindfulness Questionnaire, short form
Time Frame: Change between baseline and 15 months
|
Self-report measure consisting of 24 items divided into the subscales observing, describing, acting with awareness, non-judging and non-reactivity.
|
Change between baseline and 15 months
|
Self-Compassion Scale
Time Frame: Change between baseline and 3 months
|
Self-Compassion Scale - short form (SCS-SF).
The present study will use the 12-item Dutch short-form version of the SCS-SF to measure self-compassion.
The scale consists of six components, including self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification.
The SCS-SF has good reliability and validity (Raes et al., 2011).
In the short form, each scale consists of 2 items scored between 1 ((almost) never) to 7 ((almost) always) and subscale score ranges between 2 and 14.
A higher score indicates a higher level of self-kindness, common humanity, and mindfulness, and lower scores of self-judgment, isolation, and over-identification.
Total scores range from 12 to 84 (summed subscale scores), a higher score indicates a higher level of selfcompassion.
|
Change between baseline and 3 months
|
Self-Compassion Scale
Time Frame: Change between baseline and 15 months
|
Self-Compassion Scale - short form (SCS-SF).
The present study will use the 12-item Dutch short-form version of the SCS-SF to measure self-compassion.
The scale consists of six components, including self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification.
The SCS-SF has good reliability and validity (Raes et al., 2011).
In the short form, each scale consists of 2 items scored between 1 ((almost) never) to 7 ((almost) always) and subscale score ranges between 2 and 14.
A higher score indicates a higher level of self-kindness, common humanity, and mindfulness, and lower scores of self-judgment, isolation, and over-identification.
Total scores range from 12 to 84 (summed subscale scores), a higher score indicates a higher level of selfcompassion.
|
Change between baseline and 15 months
|
Mental Health Continuum - short form
Time Frame: Change between baseline and 3 months
|
A 14-item self-report questionnaire that assesses emotional, psychological and social well-being
|
Change between baseline and 3 months
|
Mental Health Continuum - short form
Time Frame: Change between baseline and 15 months
|
A 14-item self-report questionnaire that assesses emotional, psychological and social well-being
|
Change between baseline and 15 months
|
Inventory of Depressive Symptomatology
Time Frame: 6 months
|
A clinican-administered interview assessing the severity of depressive symptoms
|
6 months
|
Inventory of Depressive Symptomatology
Time Frame: 9 months
|
A clinican-administered interview assessing the severity of depressive symptoms
|
9 months
|
Inventory of Depressive Symptomatology
Time Frame: 12 months
|
A clinican-administered interview assessing the severity of depressive symptoms
|
12 months
|
Inventory of Depressive Symptomatology
Time Frame: 15 months
|
A clinican-administered interview assessing the severity of depressive symptoms
|
15 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Euro-Quality of Life 5D-5L
Time Frame: baseline
|
Short self-report instrument to assess quality adjusted life years
|
baseline
|
Euro-Quality of Life 5D-5L
Time Frame: 3 months
|
Short self-report instrument to assess quality adjusted life years
|
3 months
|
Euro-Quality of Life 5D-5L
Time Frame: 6 months
|
Short self-report instrument to assess quality adjusted life years
|
6 months
|
Euro-Quality of Life 5D-5L
Time Frame: 9 months
|
Short self-report instrument to assess quality adjusted life years
|
9 months
|
Euro-Quality of Life 5D-5L
Time Frame: 12 months
|
Short self-report instrument to assess quality adjusted life years
|
12 months
|
Euro-Quality of Life 5D-5L
Time Frame: 15 months
|
Short self-report instrument to assess quality adjusted life years
|
15 months
|
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: baseline
|
Health service receipt interview designed for economic evaluations in the Netherlands
|
baseline
|
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 3 months
|
Health service receipt interview designed for economic evaluations in the Netherlands
|
3 months
|
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 6 months
|
Health service receipt interview designed for economic evaluations in the Netherlands
|
6 months
|
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 9 months
|
Health service receipt interview designed for economic evaluations in the Netherlands
|
9 months
|
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 12 months
|
Health service receipt interview designed for economic evaluations in the Netherlands
|
12 months
|
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 15 months
|
Health service receipt interview designed for economic evaluations in the Netherlands
|
15 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Anne Speckens, Prof., Radboud University Medical Center
Publications and helpful links
General Publications
- Hanssen I, Scheepbouwer V, Huijbers M, Regeer E, Lochmann van Bennekom M, Kupka R, Speckens A. Adverse or therapeutic? A mixed-methods study investigating adverse effects of Mindfulness-Based Cognitive Therapy in bipolar disorder. PLoS One. 2021 Nov 4;16(11):e0259167. doi: 10.1371/journal.pone.0259167. eCollection 2021.
- Hanssen I, van der Horst N, Boele M, Lochmann van Bennekom M, Regeer E, Speckens A. The feasibility of mindfulness-based cognitive therapy for people with bipolar disorder: a qualitative study. Int J Bipolar Disord. 2020 Nov 11;8(1):33. doi: 10.1186/s40345-020-00197-y.
- Hanssen I, Huijbers MJ, Lochmann-van Bennekom MWH, Regeer EJ, Stevens AWMM, Evers SMAA, Wensing M, Kupka RW, Speckens AEM. Study protocol of a multicenter randomized controlled trial of mindfulness-based cognitive therapy and treatment as usual in bipolar disorder. BMC Psychiatry. 2019 Apr 30;19(1):130. doi: 10.1186/s12888-019-2115-6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MBCT-BD-2017-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Region StockholmKarolinska InstitutetRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II Disorder | Bipolar Affective Disorder; Remission in | Bipolar Affective Disorder, Currently Depressed, ModerateSweden
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Mayo ClinicCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
University Hospital, Strasbourg, FranceUnknownBipolar Disorder I | Bipolar Disorder II | Rapid Cycling Bipolar Disorder(DSM-IV-TR)France
-
Universiteit AntwerpenUniversitair Ziekenhuis BrusselUnknownDepression | Mood Disorders | Bipolar Disorder | Bipolar Depression | Mental Disorder | Bipolar I Disorder | Bipolar II DisorderBelgium
Clinical Trials on Mindfulness Based Cognitive Therapy
-
University of WarsawNot yet recruitingModerate Depressive Episode | Mild Depressive Episode
-
Oregon Health and Science UniversityTerminatedPostpartum Depression | Prenatal Stress | Maternal Psychological DistressUnited States
-
The University of QueenslandUniversity of Alabama at Birmingham; Rush University Medical Center; University...Completed
-
Oregon Health and Science UniversityCompletedPregnancy Related | Infant Development | Prenatal Stress | Functional Neuroimaging | Maternal Psychological DistressUnited States
-
University of WashingtonNational Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Vancouver Coastal HealthRecruitingSituational Erectile DysfunctionCanada
-
Massachusetts General HospitalMayo Clinic; University of Pennsylvania; University of South Florida; University... and other collaboratorsCompleted
-
University Medical Center GroningenUniversity of GroningenCompleted
-
University of California, Los AngelesCompletedMood Disorders | Bipolar Disorder | Parents | Prodromal Symptoms | Clinical High RiskUnited States
-
Qazvin University Of Medical SciencesUnknownInsomniaIran, Islamic Republic of